{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1032.226","meta":{"versionId":"12","lastUpdated":"2022-01-07T01:03:46.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.226","version":"20220107","name":"Cervical Precancer Disorders","status":"active","date":"2022-01-07T01:03:46-05:00","publisher":"MITRE Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-9-cm","version":"2013","concept":[{"code":"233.1","display":"Carcinoma in situ of cervix uteri"},{"code":"622.12","display":"Moderate dysplasia of cervix"},{"code":"795.02","display":"Papanicolaou smear of cervix with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)"},{"code":"795.04","display":"Papanicolaou smear of cervix with high grade squamous intraepithelial lesion (HGSIL)"}]}]}}